AI
PTCT icon

Atom Investors’s PTC Therapeutics PTCT Stock Holding History

Atom Investors’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-100,979
Closed -$3.42M – 293
2019
Q3 		$3.42M Buy
100,979
+93,952
+1,337% +$4.09M 0.23% 124
2019
Q2 		$316K Sell
7,027
-291,424
-98% -$11.5M 0.02% 336
2019
Q1 		$11.2M Buy
298,451
+99,952
+50% +$3.36M 0.95% 23
2018
Q4 		$6.81M Buy
+198,499
New +$7.14M 0.67% 26

Other funds holding PTCT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Atom Investors's PTCT Position: Q4 2019 in Review

Atom Investors sold out of PTC Therapeutics (PTCT) in Q4 2019, closing a stake of 100,979 shares — an estimated $3.42M sold.

Atom Investors first reported a position in PTCT in Q4 2018 and held it in 4 quarters. The position peaked at $11.2M in Q1 2019. 206 funds tracked by Wall St. Rank hold PTCT as of Q4 2019.

  • Atom Investors reported no remaining PTC Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Atom Investors sold 100,979 PTC Therapeutics shares in Q4 2019, an estimated $3.42M.
  • Atom Investors first reported a position in PTC Therapeutics in Q4 2018 and held it in 4 quarters.
  • Atom Investors's PTC Therapeutics position peaked at $11.2M in Q1 2019.
  • 206 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2019.

Based on Atom Investors's 13F filing for Q4 2019, filed 13 Feb 2020.